👋 HCPs, we’d value your input! We’re exploring multidisciplinary bladder cancer care. Is the following a gap in clinical practice? Inconsistent coordination between urology, oncology, and care teams, limiting timely treatment planning and shared decision-making.

📣 Calling all HCPs We’re exploring advanced bladder cancer management. Is the following a gap in clinical practice? Difficulty applying first-line treatment guidelines while proactively managing treatment-related adverse events.

💬 HCPs, can you help? We’re exploring perioperative bladder cancer treatment decisions. Is the following a gap in clinical practice? Difficulty applying emerging evidence to select and sequence perioperative therapies for muscle-invasive bladder cancer.

👋 Calling all HCPs! Help us identify educational needs in Alagille syndrome (ALGS). Is this a gap in clinical practice? Recognizing which relatives of patients with ALGS may need evaluation, particularly when symptoms are subtle or absent.

👋 Pediatric HCPs — we’d value your perspective. Is this a gap in clinical practice? Limited confidence in recognizing signs, symptoms, and diagnostic red flags suggestive of PFIC and Alagille syndrome in infants and children.

🏥 Calling HCPs caring for people with sickle cell disease. How confident are you coordinating multidisciplinary care, clarifying team responsibilities and identifying support for barriers to access and continuity?

💊 Calling HCPs caring for people with sickle cell disease. How confident are you appraising evidence for established and emerging treatments to discuss benefits, risks and treatment burden in line with each person's goals?

🥼 Calling HCPs caring for people with sickle cell disease. How confident are you anticipating changing care needs across life stages, including self-management, reproductive goals and priorities in later adulthood?

👋 Calling HCPs caring for people with sickle cell disease. How confident are you assessing fatigue, quality of life and possible organ complications beyond acute crises, and deciding next steps?

🩺Clinician insights wanted We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Integrating evidence-based weight management into coordinated, multidisciplinary knee osteoarthritis care.

📊HCP perspectives wanted We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Confidence discussing obesity and weight management with patients in a sensitive, non-stigmatizing way.

📣Calling all HCPs We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Confidence applying evidence and guidelines to lifestyle and pharmacologic weight management in knee osteoarthritis.

👋HCPs, we want to hear from you We’re exploring weight management in knee osteoarthritis. Is the following a gap in clinical practice? Recognizing obesity as a metabolic and inflammatory driver of knee osteoarthritis.

🥼 US HCPs managing metastatic castration-resistant prostate cancer, we’d value your input. How confident are you in integrating clinical assessment, lab findings and patient-reported concerns to recognize and manage symptoms and treatment toxicities in multidisciplinary care?

📣 Calling US HCPs involved in adult inflammatory or hematologic care — we’d value your insight. Is this a gap in clinical practice? HCPs lack confidence in recognizing patterns that should prompt UBA1 testing and multidisciplinary evaluation for suspected VEXAS syndrome.

📊HCP perspectives wanted! We’re exploring HER2 expression in metastatic breast cancer. Is the following a gap in clinical practice? Inadequate multidisciplinary workflows for integrating HER2 IHC results into timely treatment decisions.

📣Calling all HCPs We’re exploring HER2 expression in metastatic breast cancer. Is the following a gap in clinical practice? Inconsistent HER2 terminology, reporting and communication between pathology and oncology teams.

👋HCPs, we want to hear from you We’re exploring HER2 expression in metastatic breast cancer. Is the following a gap in clinical practice? Interpreting HER2 0, HER2 0 with membrane staining, HER2 1+ and HER2 2+, and their clinical significance.

👋 Calling HCPs involved in systemic sclerosis care, we’d value your perspective. To what extent is integrating early clinical features, serology, nailfold capillaroscopy and phenotype to recognise systemic sclerosis and characterise initial risk a gap in practice?

Help us improve Alzheimer's care 📈 How confident are you in utilizing standardized communication and rapid escalation protocols to ensure safe, coordinated ARIA management in an emergency setting?